Pharma & Biotech

While Ocugen faces immediate pressure from a collapsed acquisition deal, the biotech firm is simultaneously receiving strong endorsements from two...

Investors in Essa have reacted harshly to a severe downgrade in the proposed terms for its business combination with XenoTherapeutics....

Mersana Therapeutics shares continued their upward trajectory, closing Friday's session with a substantial 5.58% gain at $7.57. This advance extends...

Jasper Therapeutics finds itself navigating turbulent waters as the biotechnology firm contends with a complex mix of regulatory developments, financial...

Shares of Aldeyra Therapeutics experienced a significant rally, climbing 2.92% to reach a price of $5.26. This upward movement is...

Shareholders of Verona Pharma have officially greenlit the company's proposed acquisition by pharmaceutical giant Merck. The $10 billion deal is...

The continuous glucose monitoring specialist DexCom finds itself navigating turbulent waters. Despite strong underlying demand for glucose monitoring systems, the...

Shares of Capricor Therapeutics experienced a significant 10% surge yesterday, closing at $6.79. This substantial gain was driven by a...

Danish pharmaceutical leader Novo Nordisk has unveiled a significant global restructuring plan that will eliminate approximately 9,000 positions. The workforce...

Idorsia Ltd. shares are currently caught in a storm of market volatility, with significant price swings and unusually heavy trading...